Plasminogen activator inhibitor-1 and restenosis.
Despite the introduction of drug-eluting stents restenosis remains an important clinical problem. In this review we examine the role of plasminogen activator inhibitor-1 (PAI-1) in controlling restenosis after balloon angioplasty and stent implantation.
Garg
Nadish
N
Department of Internal Medicine, University of Missouri School of Medicine, Columbia, MO, USA.
Fay
William P
WP
D015906:Angioplasty, Balloon, Coronary; D000818:Animals; D023903:Coronary Restenosis / Q000097:blood* / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D006965:Hyperplasia / Q000209:etiology / Q000378:metabolism; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism*; D017539:Tunica Intima / Q000473:pathology
D017395:Plasminogen Activator Inhibitor 1